Profile
Adam Watkinson worked as the Chief Scientific Officer at Acrux Ltd.
from 2005 to 2011.
He also worked as a Manager-Project & Delivery Research at Kyowa Kirin International Plc.
Dr. Watkinson received his undergraduate degree from the University of Bath and his MBA and doctorate from the University of Cardiff.
Former positions of Adam Watkinson
Companies | Position | End |
---|---|---|
ACRUX LIMITED | Chief Tech/Sci/R&D Officer | 2011-05-19 |
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Corporate Officer/Principal | - |
Training of Adam Watkinson
University of Cardiff | Doctorate Degree |
University of Bath | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ACRUX LIMITED | Health Technology |
Private companies | 1 |
---|---|
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Adam Watkinson